The researchers said that examining the FGF21 allele could cast light on potential adverse and beneficial effects of therapies that target the gene.
With the help of electronic health record data, researchers searched for common variants linked to hundreds of diseases or clinical lab measurements.
Through a genome-wide association study and meta-analysis, researchers saw dozens of new and known blood pressure loci, including ancestry-specific associations.
Independent research teams identified mutations in a chloride ion channel gene in some cases of aldosteronism, a condition that can cause severe hypertension.
In a pilot study of 92 individuals with familial or suspected genetic chronic kidney disease, researchers successfully diagnosed 24 percent of cases with exome sequencing.
Gut microbiome researchers have identified features associated with everything from Crohn's disease to salt intake, immune activity, and hypertension.
On a conference call, the firm's CEO said that it and other industry players are pushing to postpone implementation of PAMA to no earlier than July 1, 2018.
In PLOS this week: blood pressure and hypertension loci in people of African ancestry, Plasmodium vivax population genomics, and more.
Geneticure has raised around $1.1 million to fund the study, which may very well be the largest prospective RCT for personalization of high blood pressure treatment.
In Nature this week: a CRISPR/Cas9 system that can be toggled, and more.
Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.
The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.
In Science this week: genetic overlap among many psychiatric disorders, and more.
The Economist writes that an increasing number of scientific journals don't do peer review.